Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Exp Neurol. 2019 May 10;318:244–250. doi: 10.1016/j.expneurol.2019.05.003

Figure 4.

Figure 4.

Deferoxamine (DFX) treatment reduced hemin levels in (A) hematoma and (B) perihematomal tissue at day 3 and 7 following ICH. n=4 for each group. * p<0.05, compared with the vehicle-treated group; ** p<0.05 compared with day 3.